Impact Review 2025
See our latest review

Impact investing is not about trade-offs—it is about unlocking
value where markets and societies need solutions most.

Impact Achieved in 2025

Climate
tonnes of emissions avoided
2000000
Social
total individuals reached
48000000
Healthcare
total patients reached
5000000
Education
total stakeholders reached
22000000
Financial Inclusion
individuals & MSMEs reached
7000000
Agriciulture
total farmers reached
12000000
Employment
Individuals employed
30000
OTHER ENVIRONMENTAL IMPACTS
tonnes of fugitive plastic pollution avoided
4000
tonnes of food waste avoided
40000
 
tonnes of fishing avoided
15000
litres of water saved
57000000000

New investments from ABC Impact Fund II

AC Health

COMPANY OVERVIEW

AC Health is an integrated healthcare platform in the Philippines, operating across both provider and pharmaceutical segments. As one of the emerging business units of Ayala Corporation, the business spans hospitals, clinics, retail pharmacies and pharmaceutical distribution, forming a nationwide network across the patient care continuum.

Its provider segment includes a network of primary and specialty clinics alongside secondary and tertiary hospitals, while its pharma segment comprises importation, wholesale distribution and a national retail pharmacy network. Together, these capabilities position AC Health as an end-to-end platform delivering coordinated care across multiple points of access.

LIVES TOUCHED THROUGH AC HEALTH’S NETWORK
1 M

IMPACT THESIS

Strengthening health system capacity and coverage in the Philippines through an integrated provider and pharma platform, by enhancing availability, affordability and quality of care for better population health.

DCDC Kidney Care

COMPANY OVERVIEW

DCDC Kidney Care is one of India’s largest dialysis providers and the leading operator within the public–private partnership (PPP) segment. The company focuses on delivering life-sustaining dialysis treatment for patients with end-stage renal disease (ESRD), with a particular emphasis on underserved populations across Tier III cities and beyond.

It operates a network of dialysis centres across multiple states through a combination of PPP arrangements with public hospitals, standalone centres, and partnerships with private hospitals, enabling it to serve patients across different income segments and care settings.

PATIENTS RECEIVED DIALYSIS CARE SINCE INVESTMENT
40000
RECEIVED FULLY SUBSIDISED TREATMENT
10 %
CENTRES ACROSS INDIA
100
ARE ESTABLISHED THROUGH PPP ARRANGEMENTS
10 %

IMPACT THESIS

Strengthening India’s health system capacity to deliver quality dialysis care by reducing availability and affordability barriers for underserved segments, enabling improved clinical and health outcomes.

HistoSonics

COMPANY OVERVIEW

HistoSonics is a global MedTech company advancing histotripsy in oncological therapy – a non-invasive, ultrasound-based therapy that mechanically destroys targeted tumour tissue. Its Edison platform received U.S. FDA De Novo approval in October 2023 for the treatment of liver tumours, following demonstrated technical success rates of 95.5%.

Unlike conventional thermal or surgical approaches, histotripsy uses focused ultrasound to mechanically disrupt tissue, representing a distinct mechanism of action with potential clinical advantages in precision and safety.

PATIENTS PROVIDED WITH HISTOTRIPSY PROCEDURE
1000 +

IMPACT THESIS

Pioneering a tumour therapy
option with enhanced precision and safety with reduced risk of adverse effects, addressing treatment access barriers for higher-risk patients, while fostering innovation in the onco- therapeutic space.

NeuroGen

COMPANY OVERVIEW

NeuroGen is an integrated pharmaceutical platform focused on central nervous system (CNS) therapies in China, addressing a broad range of neurological conditions including epilepsy, Parkinson’s disease and allergies.

Originating from UCB’s China operations and now independently established, the company combines a portfolio of established therapies with manufacturing and distribution capabilities. This provides a stable operating base while supporting continued expansion through in- licensing and pipeline development.

PATIENTS RECEIVED THROUGH NEUROGEN’S ANTI-EPILEPTIC SOLUTIONS SINCE INVESTMENT
300000

IMPACT THESIS

Driving better health and quality-of- life outcomes for patients in China through its portfolio of safe and efficacious CNS medicines, while strengthening pharmaceutical supply chains to improve drug availability in the country.

Vistaar Finance

COMPANY OVERVIEW

Founded in 2010, Vistaar Finance is a non-banking financial company (NBFC) providing secured lending solutions to micro, small and medium enterprises (MSMEs) across India. The company operates through a network of nearly 300 branches spanning rural and semi-urban regions, serving businesses across sectors including trading, services, manufacturing and hospitality.

Its product suite includes small- and medium-ticket business loans, affordable housing loans and gold loans, enabling it to support borrowers across different stages of their business lifecycle. This diversified, secured lending model provides both stability and flexibility in addressing a wide range of financing needs.

LIVES TOUCHED THROUGH VISTAAR’S FINANCIAL PRODUCTS SINCE INVESTMENT
100000
BORROWERS REACHED SINCE INVESTMENT
60000

IMPACT THESIS

Enhancing business productivity and improving livelihoods of small business owners in India, through better availability of timely and affordable credit.

About ABC Impact

We are a private equity firm dedicated to impact investing. Headquartered in Singapore, we invest in companies generating meaningful impact and creating positive change in Asia.

INTEGRATING IMPACT INTO INVESTMENTS

We adopt a proprietary impact measurement and management system that is integrated into our investment process. This helps us monitor impact performance and ensure portfolio companies deliver impact outcomes, alongside financial returns. Through evidence-based research and industry-aligned metrics, we invest in companies whose products and services help advance the UN Sustainable Development Goals.

A DIVERSE TEAM

We are a diverse team of professionals who understands Asia and its vast potential for impact at scale. With cross-functional expertise and experience from impact investing, private equity, portfolio management, legal, and non-governmental organisations, we are united in the mission to make a difference to our environment and the communities in Asia.

INSIGHTS

Fostering impact at scale through private capital

As part of our mission, we develop insightful studies, commission independent research, and share our perspectives on various environmental and social impact challenges around the world.

Driving measurable and positive impact alongside compelling financial returns

What We Invest In

Acceleration & Growth Stage

We primarily invest in impact-driven companies seeking capital to finance early growth and expansion.

Impactful

We focus on founders and companies with strong impact intentionality, driving outcomes in line with the UN Sustainable Development Goals.

Asia Focused

We seek to support companies whose products and services have the potential to address Asia’s biggest challenges.

OUTCOMES

A Growing Portfolio

A global mandate, with an Asia focus

Chongho Bridge’s economical rural services enable borrowers to invest in their livelihoods, achieve financial resilience, and ultimately better their standards of living.

China

No Poverty Decent Work and Economic Growth

Primary Impact

Reduced Inequalities

Secondary Impact

Rural communities require enabling capital to advance the economy

China has the world’s largest unbanked population of nearly 287 million people, with majority in rural areas. These rural communities typically comprise micro-entrepreneurs or small-scale enterprises that are unable to sustain or scale with insufficient financial resources.

As MSMEs account for 97% of registered businesses and 82% of employment in the country, limited access to financial services has been and continues to be a significant barrier to economic development in rural China. The success and revitalisation of these rural communities and economy are integral to the continued growth of the Chinese economy.

Investing in affordable microfinance solutions to revitalise the rural economy

Chongho Bridge’s convenient, fast, and economical rural services enable borrowers to invest in their livelihoods, achieve financial resilience, and ultimately better their standards of living. Better business prospects also enable customers to improve their working conditions and provide more employment opportunities to their communities.

Chongho Bridge facilitates the achievement of sustainable economic development in these rural populations. Our investment in the company highlights our commitment to advancing financial inclusion and reducing inequalities for underserved communities.

HCAH offers a diverse suite of specialised out-of-hospital services at affordable prices that improve quality and access to health services while easing the burden on health systems in India.

India

Good Health and Well-Being

Primary Impact

Myriad of challenges for India’s health sector

COVID-19, rapid urbanisation and the rising burden of chronic diseases pose major health challenges globally. In India, issues around access and affordability of healthcare services further magnify these problems for its health systems and population. As demand consistently increases, the country’s supply infrastructure is further constrained, both in terms of quality and quantity. Shortages in health workforce and resources as well as limited organised healthcare providers result in India’s population experiencing fragmented, sub-optimal care – within and outside the hospital.

Investing in out-of-hospital care to transform healthcare delivery models

We invested in HealthCare atHOME (HCAH) for its two-fold ability to deliver positive benefits at both the individual and systemic level. HCAH offers a diverse suite of specialised out-of-hospital services at affordable pricing, ranging from ICU-at-home to rehabilition services and recently, COVID care. By providing alternate care delivery structures, HCAH contributes to improving the access and quality of health services for patients, while offering systemic relief to India’s constrained supply infrastructure. HCAH’s out-of-hospital model also ensures patients receive continuous care with reduced risk of hospital readmissions and infections, driving better health outcomes for the population.

Kim Dental reaches an underserved population and addresses the oral care needs of the country’s emerging middle class.

Vietnam

Good Health and Well-Being

Primary Impact

Oral health remains neglected in the overall health agenda

Oral diseases affect over 3.5 billion people globally. Poor oral health remains a silent epidemic, particularly for low- and middle-income countries and their disadvantaged populations. Maintaining good oral health is also fundamental to overall health as oral diseases often share risk factors and social determinants with numerous other non-communicable diseases.

Investing to address inequalities in access to oral healthcare

We invested in Kim Dental to bridge the access gap for oral healthcare in Vietnam. Through its affordable range of dental services, Kim Dental is able to reach an underserved population and meet the oral care needs of the country’s emerging middle class. It also bolsters health infrastructure and workforce through its quality clinics and training initiatives, to contribute to an increasing standard of oral health services throughout the country.

INVESTMENT THEMES

We focus on thematic areas that can reframe the region’s most pressing environmental and social challenges into growth and development opportunities.

Climate & Water
Solutions
Financial & Digital Inclusion
Better Healthcare & Education
Sustainable Food & Agriculture